Intra-Cellular Therapies Inc (ITCI)
64.99
-1.54
(-2.31%)
USD |
NASDAQ |
May 17, 16:00
64.99
0.00 (0.00%)
After-Hours: 20:00
Intra-Cellular Therapies Free Cash Flow: -98.25M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -98.25M |
December 31, 2023 | -124.47M |
September 30, 2023 | -161.57M |
June 30, 2023 | -189.50M |
March 31, 2023 | -247.62M |
December 31, 2022 | -270.96M |
September 30, 2022 | -304.98M |
June 30, 2022 | -331.09M |
March 31, 2022 | -295.52M |
December 31, 2021 | -259.87M |
September 30, 2021 | -255.00M |
June 30, 2021 | -239.17M |
March 31, 2021 | -226.86M |
December 31, 2020 | -230.34M |
September 30, 2020 | -196.43M |
June 30, 2020 | -162.89M |
March 31, 2020 | -144.24M |
December 31, 2019 | -128.68M |
September 30, 2019 | -123.50M |
June 30, 2019 | -121.71M |
Date | Value |
---|---|
March 31, 2019 | -126.98M |
December 31, 2018 | -118.56M |
September 30, 2018 | -114.65M |
June 30, 2018 | -100.74M |
March 31, 2018 | -92.07M |
December 31, 2017 | -81.22M |
September 30, 2017 | -84.36M |
June 30, 2017 | -99.51M |
March 31, 2017 | -88.08M |
December 31, 2016 | -91.31M |
September 30, 2016 | -97.95M |
June 30, 2016 | -88.90M |
March 31, 2016 | -106.57M |
December 31, 2015 | -103.14M |
September 30, 2015 | -74.26M |
June 30, 2015 | -58.06M |
March 31, 2015 | -32.06M |
December 31, 2014 | -22.82M |
September 30, 2014 | -16.61M |
Free Cash Flow Range, Past 5 Years
-331.09M
Minimum
Jun 2022
-98.25M
Maximum
Mar 2024
-205.63M
Average
-211.64M
Median
Free Cash Flow Benchmarks
Johnson & Johnson | 18.23B |
Insmed Inc | -588.55M |
Madrigal Pharmaceuticals Inc | -391.12M |
Vertex Pharmaceuticals Inc | 3.479B |
Fate Therapeutics Inc | -139.78M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -34.12M |
Cash from Investing (Quarterly) | 16.18M |
Cash from Financing (Quarterly) | 9.989M |
Free Cash Flow Per Share (Quarterly) | -0.3522 |
Free Cash Flow to Equity (Quarterly) | -34.12M |
Free Cash Flow to Firm (Quarterly) | -34.12M |
Free Cash Flow Yield | -1.57% |